Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Breast Neoplasms × Technetium-99 × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Surveys and Questionnaires 65 Blood Specimen Collection 52 palbociclib 35 Trastuzumab 29 Immunohistochemistry 26 Letrozole 24 Drug Therapy 22 Anastrozole 22 Radiotherapy 20 Tamoxifen 18 Gene Expression Profiling 18 Biopsy 18 exemestane 17 Interviews as Topic 17 Amplified Fragment Length Polymorphism Analysis 17 ribociclib 16 Mastectomy, Segmental 16 Fulvestrant 16 Mastectomy 14 Magnetic Resonance Spectroscopy 13 Psychiatric Rehabilitation 12 Paclitaxel 12 Observation 12 High-Energy Shock Waves 12 Capecitabine 12 trastuzumab deruxtecan 11 Polymerase Chain Reaction 11 Neoadjuvant Therapy 11 Microarray Analysis 11 Reverse Transcriptase Polymerase Chain Reaction 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06378944 2024-09-19

INSEAN

Omphis Foundation

15,000 enrolled

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡